Clinical Trial Update: A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating erlotinib in combination with radiotherapy for patients with advanced or inoperable non-small cell lung cancer; the trial is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Carcinoma, Non-small-cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2018-01-30